Effect | Decrease |
Trial Design | Double blind |
Trial Length | 6+ Months |
Number of Subjects | 21 |
Sex | n/a |
Age Range | 30-44, 45-64 |
Curcuminoids, at three daily doses of 250mg, is associated with lessening the oxidative damage in beta-thalassemia/Hb E patients. Glutathione peroxidase and superoxide dismutase were both increased in the red blood cells of patients given curcumin.